News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Waltzman Roger J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
4
| Waltzman Roger J. (Chief Medical Officer) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $1.85, valued at
$166.5k
|
|
| 08/07/2023 |
3
| Waltzman Roger J. (Chief Medical Officer) has filed a Form 3 on Indaptus Therapeutics, Inc. |
| 02/17/2022 |
4
| Waltzman Roger J. (See remarks) has filed a Form 4 on Molecular Templates, Inc.|
Txns:
| Granted 125,000 options to buy
@ $2.77, valued at
$346.3k
|
|
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/16/2016 |
4
| Waltzman Roger J. (Chief Scientific Officer) has filed a Form 4 on Jaguar Animal Health, Inc.|
Txns:
| Granted 127,500 options to buy
@ $1.47, valued at
$187.4k
|
|
| 07/07/2016 |
3
| Waltzman Roger J. (Chief Scientific Officer) has filed a Form 3 on Jaguar Animal Health, Inc. |
|
|